SAMUEL GANZ, D.O.
Internal Medicine Physician · DELRAY BEACH, FL
Individual Active NPI 1447591714
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 2,141 | 1,871,125 | $42,741,766 | $21,724,726 | $17,332,772 |
| 2023 | 957 | 402,193 | $24,569,336 | $11,271,212 | $8,967,756 |
| 2022 | 327 | 86,217 | $10,747,339 | $5,352,738 | $4,262,336 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0174 | Injection, lecanemab-irmb, 1 mg | 1,047,290 | $1 | $1 |
| J1306 | Injection, inclisiran, 1 mg | 234,016 | $12 | $10 |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 152,880 | $11 | $8 |
| J0897 | Injection, denosumab, 1 mg | 82,140 | $26 | $21 |
| J0175 | Injection, donanemab-azbt, 2 mg | 54,950 | $4 | $3 |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 40,800 | $0 | $0 |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 18,000 | $22 | $17 |
| J2356 | Injection, tezepelumab-ekko, 1 mg | 13,860 | $18 | $14 |
| J3245 | Injection, tildrakizumab, 1 mg | 8,400 | $135 | $108 |
| J2182 | Injection, mepolizumab, 1 mg | 8,000 | $30 | $24 |
| J3241 | Injection, teprotumumab-trbw, 10 mg | 6,400 | $330 | $263 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 6,250 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Internal Medicine Physician | 207R00000X | ✓ | OS17434 | FL |
| Internal Medicine Physician | 207R00000X | OS017841 | PA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Internal Medicine Physician providers in Florida
- NPI 1760784870
- NPI 1700389665
- NPI 1326778531
- NPI 1730128406
- NPI 1003443011
- NPI 1598030132
- NPI 1013580356
- NPI 1881718989
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.